Apple says Uighurs targeted in iPhone attack but disputes Google findings
FILE PHOTO: A woman looks at the screen of her mobile phone in front of an Apple logo outside its store in Shanghai, China July 30, 2017. REUTERS/Aly Song/File Photo…
by October Gallery
FILE PHOTO: A woman looks at the screen of her mobile phone in front of an Apple logo outside its store in Shanghai, China July 30, 2017. REUTERS/Aly Song/File Photo…
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland October 23, 2017. REUTERS/Arnd Wiegmann ZURICH (Reuters) – Novartis has…
(Reuters) – A Los Angeles County resident has died from a lung illness possibly tied to vaping, bringing the total number of such U.S. deaths to five, health officials said…
(Reuters) – The U.S. health regulator on Thursday categorized the recall of Edwards Lifesciences Corp’s Sapien 3 Ultra delivery system as extremely serious, highlighting health risks associated with its use,…
WASHINGTON (Reuters) – Four dominant e-cigarette manufacturers face a probe into the health impacts of their products, as the U.S. House Energy and Commerce Committee asked on Wednesday about the…
(Reuters) – Teva Pharmaceutical Industries Ltd on Tuesday made its generic version of Mylan’s EpiPen for young children available in most retail pharmacies at $300 for a 2-pack. EpiPen auto-injection…
NEW YORK/SAN FRANCISCO (Reuters) – Alphabet Inc’s Google has shut down a service it provided to wireless carriers globally that showed them weak spots in their network coverage, people familiar…
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in Shanghai May 22, 2014. REUTERS/Aly Song (Reuters) – The U.S.…
SINGAPORE/WASHINGTON (Reuters) – The U.S. Commerce Department is expected to extend a reprieve given to Huawei Technologies that permits the Chinese firm to buy supplies from U.S. companies so that…
NEW YORK (Reuters) – Novartis AG said on Wednesday it replaced the two top research and development executives at its Avexis unit after some data was manipulated from early testing…